Literature DB >> 21452302

Cytokine expression in muscle following traumatic injury.

Wesley M Jackson1, Amber B Aragon, Jun Onodera, Steven M Koehler, Youngmi Ji, Jamie D Bulken-Hoover, Jared A Vogler, Rocky S Tuan, Leon J Nesti.   

Abstract

Heterotopic ossification (HO) occurs at a high frequency in severe orthopaedic extremity injuries; however, the etiology of traumatic HO is virtually unknown. Osteogenic progenitor cells have previously been identified within traumatized muscle. Although the signaling mechanisms that lead to this dysregulated differentiation pathway have not been identified, it is assumed that inflammation and fibrosis, which contribute to an osteoinductive environment, are necessary for the development of HO. The hypothesis of this study was that cytokines related to chronic inflammation, fibrogenesis, and osteogenesis become up-regulated following severe muscle trauma where HO forms. Classification of these cytokines by their differential expression relative to control muscle will provide guidance for further study of the mechanisms leading to HO. Real-time RT-PCR analysis revealed no significant up-regulation of cytokines typically associated with HO (e.g., BMP-4, as observed in the genetic form of HO, fibrodysplasia ossificans progressiva). Instead, the cytokine gene expression profile associated with the traumatized muscle included up-regulation of cytokines associated with osteogenesis and fibrosis (i.e., BMP-1 and TGF-β(1)). Using immunohistochemistry, these cytokines were localized to fibroproliferative lesions, which have previously been implicated in HO. This study identifies other cell and tissue-level interactions in traumatized muscle that should be investigated further to better define the etiology of HO.
Copyright © 2011 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21452302      PMCID: PMC3150639          DOI: 10.1002/jor.21354

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  22 in total

1.  Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix.

Authors:  R C Spiro; A Y Thompson; J W Poser
Journal:  Anat Rec       Date:  2001-08-01

2.  Current concepts in the development of heterotopic ossification.

Authors:  H C Pape; S Marsh; J R Morley; C Krettek; P V Giannoudis
Journal:  J Bone Joint Surg Br       Date:  2004-08

3.  Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.

Authors:  Jaimo Ahn; Lourdes Serrano de la Pena; Eileen M Shore; Frederick S Kaplan
Journal:  J Bone Joint Surg Am       Date:  2003-04       Impact factor: 5.284

4.  Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.

Authors:  A B Shafritz; E M Shore; F H Gannon; M A Zasloff; R Taub; M Muenke; F S Kaplan
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

5.  Myostatin regulation during skeletal muscle regeneration.

Authors:  S Kirk; J Oldham; R Kambadur; M Sharma; P Dobbie; J Bass
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

Review 6.  Heterotopic ossification.

Authors:  Frederick S Kaplan; David L Glaser; Nader Hebela; Eileen M Shore
Journal:  J Am Acad Orthop Surg       Date:  2004 Mar-Apr       Impact factor: 3.020

7.  Putative heterotopic ossification progenitor cells derived from traumatized muscle.

Authors:  Wesley M Jackson; Amber B Aragon; Jamie D Bulken-Hoover; Leon J Nesti; Rocky S Tuan
Journal:  J Orthop Res       Date:  2009-12       Impact factor: 3.494

Review 8.  Muscle contusion injury and myositis ossificans traumatica.

Authors:  John M Beiner; Peter Jokl
Journal:  Clin Orthop Relat Res       Date:  2002-10       Impact factor: 4.176

9.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.

Authors:  M Shah; D M Foreman; M W Ferguson
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

10.  Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.

Authors:  M Shah; D M Foreman; M W Ferguson
Journal:  J Cell Sci       Date:  1994-05       Impact factor: 5.285

View more
  22 in total

1.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.

Authors:  Michael N Wosczyna; Arpita A Biswas; Catherine A Cogswell; David J Goldhamer
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 2.  Muscle-bone interactions: basic and clinical aspects.

Authors:  Luisella Cianferotti; Maria Luisa Brandi
Journal:  Endocrine       Date:  2013-08-29       Impact factor: 3.633

3.  The skeletal muscle secretome: an emerging player in muscle-bone crosstalk.

Authors:  Mark W Hamrick
Journal:  Bonekey Rep       Date:  2012-04-11

4.  Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Authors:  Frédéric Torossian; Bernadette Guerton; Adrienne Anginot; Kylie A Alexander; Christophe Desterke; Sabrina Soave; Hsu-Wen Tseng; Nassim Arouche; Laetitia Boutin; Irina Kulina; Marjorie Salga; Beulah Jose; Allison R Pettit; Denis Clay; Nathalie Rochet; Erica Vlachos; Guillaume Genet; Charlotte Debaud; Philippe Denormandie; François Genet; Natalie A Sims; Sébastien Banzet; Jean-Pierre Levesque; Jean-Jacques Lataillade; Marie-Caroline Le Bousse-Kerdilès
Journal:  JCI Insight       Date:  2017-11-02

Review 5.  Microenvironmental factors that regulate mesenchymal stem cells: lessons learned from the study of heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Histol Histopathol       Date:  2017-03-22       Impact factor: 2.303

6.  Galectin-1 promotes an M2 macrophage response to polydioxanone scaffolds.

Authors:  Daniel Abebayehu; Andrew Spence; Barbara D Boyan; Zvi Schwartz; John J Ryan; Michael J McClure
Journal:  J Biomed Mater Res A       Date:  2017-06-15       Impact factor: 4.396

7.  Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation.

Authors:  Brandon J Ausk; Ted S Gross; Steven D Bain
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

Review 8.  Traumatic muscle fibrosis: From pathway to prevention.

Authors:  David Cholok; Eric Lee; Jeffrey Lisiecki; Shailesh Agarwal; Shawn Loder; Kavitha Ranganathan; Ammar T Qureshi; Thomas A Davis; Benjamin Levi
Journal:  J Trauma Acute Care Surg       Date:  2017-01       Impact factor: 3.313

Review 9.  Conserved signaling pathways underlying heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Na Ding; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Bone       Date:  2017-04-25       Impact factor: 4.398

Review 10.  Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.

Authors:  Anderson Martelli; Arnaldo Rodrigues Santos
Journal:  Organogenesis       Date:  2014-10-31       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.